Clinical and Agbio Markets Boost Affymetrix Q2 Sales Affymetrix second quarter sales grew 4.1%, 7.9% excluding currency, to $89.0 million. Organic growth was driven by agbio and clinical sales, which climbed 24% and roughly 20%, respectively. Overall, consumables and instrument sales grew 4.8% and 16.8%, to account for 86% and 4% of revenues, respectively. Service […]
Santa Clara, CA and Billerica, MA 9/9/15—Agilent Technologies has definitively agreed to acquire Seahorse Bioscience for $235 million in cash. Seahorse provides instruments and assay kits for measuring cell metabolism and bioenergetics. Founded in 2001 and employing nearly 200 people, Seahorse is expected to generate $49 million in fiscal 2015 revenues. “Seahorse Bioscience’s unique technology […]
Agilent Lowers Outlook Given currency and the discontinued NMR business (see IBO 3/31/15), which reduced sales growth by 7% and 1%, respectively, Agilent Technologies fiscal third quarter sales ending July 31 grew 0.5% to $1,014 million (see page 12). Despite the modest growth, sales were above analysts’ expectations. Core sales, which exclude the NMR business, […]
The devaluation of China’s yuan sparked an extensive sell-off in the global equity markets in August. The S&P 500 and NASDAQ contracted 9% or more on three consecutive trading days beginning August 20. Despite strong surges on August 26, the Dow, S&P 500 and NASDAQ fell 6.6%, 6.3% and 6.9% for the month, respectively. The […]
Calendar year second quarter organic growth continued at a strong pace for major US publicly held instrument and laboratory product companies. However, currency headwinds, as well as weakness in industrial markets and Japan expunged organic growth. Currency reduced gains by about 7%, resulting in roughly flat second quarter average sales growth. Pharmaceutical and biotechnology markets […]
The US Bureau of Economic Analysis (BEA) released this month the latest figures for US companies’ R&D domestic spending and R&D spending by foreign-owned affiliates. The report shows dramatic shifts in annual R&D spending by both segments in recent years among industries that are major purchasers of analytical instruments. The data provide quantitative information on […]
Slow Growth for Bruker Despite higher-than-expected sales and sequential growth, Bruker’s Scientific Instruments (BSI) second quarter sales grew just 0.6% to $366.2 million to account for 92% of revenues (see page 12). Bruker BioSpin sales fell in the mid-single digits due to lower demand in Preclinical Imaging, which accounts for 20% of Group sales. The […]
Company Announcements In June, Spark Holland named LEAP Technologies as a value-added partner for US distribution. LEAP will initially focus on automated at-line systems integrated with the CTC PAL3 platforms and universal CHRONOS software. Phenomenex acquired Micron Analytica, its Spanish distribution partner, in June. Illumina, Merck KGaA and Genea established the Global Fertility Alliance to […]
Seven federal agencies—the Department of Defense (DOD), DOE’s National Nuclear Security Administration (NNSA), FDA, NIH, NIST, NSF and Department of Veterans Affairs (VA)—conducted or funded research in regenerative medicine from fiscal 2012–14 (FY12–14). The agencies invested about $2.89 billion in the research during this time, with the NIH accounting for about 88% of this spending. […]
Major US equity markets traded higher in July despite mixed corporate earnings, soft economic data and China’s plunging stock market. While the Federal Reserve quantified a more positive economic outlook, second quarter US GDP estimates fell below expectations. Second quarter GDP growth expanded 2.3% versus a consensus of 2.9%. However, first quarter US GDP growth […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
